Clinical trial
Cerebral Protection in Transcatheter Aortic Valve Replacement
NCT02214277 · Claret Medical, Industry · Completed
Key facts
| NCT number | NCT02214277 |
|---|---|
| Title | Cerebral Protection in Transcatheter Aortic Valve Replacement |
| Official title | Cerebral Protection in Transcatheter Aortic Valve Replacement - The SENTINEL Study |
| Lead sponsor | Claret Medical, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Severe Symptomatic Calcified Native Aortic Valve Stenosis |
| Intervention type | Device |
| Interventions | Cerebral Protection System-The SENTINEL System with TAVR, TAVR |
| Enrollment | 363 |
| Start date | Sep 1, 2014 |
| Primary completion | Mar 1, 2016 |
| Completion | Jun 1, 2016 |
| First posted | Aug 12, 2014 |
| Last update posted | May 11, 2018 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: